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Gram-negative bacterial infections are accompanied by inﬂammation and somatic or
visceral pain. These symptoms are generally attributed to sensitization of nociceptors
by inﬂammatory mediators released by immune cells. Nociceptor sensitization during
inﬂammation occurs through activation of the Toll-like receptor 4 (TLR4) signalling pathway
by lipopolysaccharide (LPS), a toxic by-product of bacterial lysis. Here we show that LPS
exerts fast, membrane delimited, excitatory actions via TRPA1, a transient receptor potential
cation channel that is critical for transducing environmental irritant stimuli into nociceptor
activity. Moreover, we ﬁnd that pain and acute vascular reactions, including neurogenic
inﬂammation (CGRP release) caused by LPS are primarily dependent on TRPA1 channel
activation in nociceptive sensory neurons, and develop independently of TLR4 activation. The
identiﬁcation of TRPA1 as a molecular determinant of direct LPS effects on nociceptors offers
new insights into the pathogenesis of pain and neurovascular responses during bacterial
infections and opens novel avenues for their treatment.
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G
ram-negative bacteria are a major class of human
pathogens comprising many different virulent species1.
Infections by these bacteria cause diseases that represent
serious global health problems such as pneumonia, meningitis,
gastroenteritis and gonorrhoea. The mammalian innate immune
system uses a limited set of pattern-recognition receptors to
trigger defence mechanisms against microbial infections2,3. The
most potent immunostimulatory cue produced by Gram-negative
bacteria is lipopolysaccharide (LPS), an abundant outer wall
glycolipid that is released locally and into the circulation on
bacterial lysis. In vertebrates, the lipid portion of LPS, termed
lipid A, binds to the protein complex formed by MD-2 and Toll-
like receptor 4 (TLR4) in immune cells. This triggers the synthesis
of proinﬂammatory cytokines (tumour necrosis factor (TNF)-a,
interleukin (IL)-1, IL-6) that, through the recruitment of
macrophages and eosinophils, induce inﬂammation and pain,
followed by eventual bacterial lysis and clearance4,5.
However, the response of the immune system is relatively slow
and cannot account for some of the immediate effects of LPS. For
instance, tail-ﬂick hyperalgesia starts a few minutes after
intraperitoneal (i.p.) LPS injection6. Also, LPS produces a
strong fall in blood pressure within minutes of injection, long
before TNF-a is detectable in the circulation7. Interestingly,
nociceptive and vascular responses to injected LPS are abrogated
by section of visceral sensory afferents6,8,9 implying a neural
component that would act as a fast pathway in the LPS signalling
mechanism. LPS can activate sensory neurons in culture10,11.
Moreover, the recent identiﬁcation of TLR4 in sensory neurons
suggested that some of the rapid LPS effects could be mediated by
direct stimulation of sensory afferents10–12. Nonetheless, no
molecular mechanism has yet been put forward to relate TLR4
stimulation to the fast activation of sensory neurons.
Here we use a combination of techniques, including electrical
recordings of primary sensory neurons, the application of
blockers of TLR4 signalling and behavioural testing in different
transgenic mice, and obtained conclusive evidence that TRPA1-
expressing peripheral sensory afferents are directly activated by
LPS in a TLR4-independent manner. We also dissect out the
molecular mechanisms linking LPS exposure to the activation of
peptidergic sensory terminals and the development of acute
neurogenic inﬂammation and pain. Collectively, these ﬁndings
could lead to new strategies for the treatment of pain,
inﬂammation and vascular shock during bacterial infections.
Results
LPS activates TRPA1-expressing nociceptors. Using intracel-
lular calcium imaging, we found that LPS extracted from
Escherichia coli (10 mgml 1) stimulated 17.8% (32/180) of wild-
type (WT) mouse nodose (that is, vagal) sensory neurons
innervating the viscera (Fig. 1a,d). Notably, nodose neurons
isolated from Tlr4 knockout (KO) mice responded to LPS with
similar incidence (32/136, P¼ 0.26, Fisher’s exact test; Fig. 1b,d)
and amplitude (P¼ 0.6, unpaired t-test; Supplementary Fig. 1b),
thus excluding mediation of this effect by TLR4. Interestingly, the
vast majority of WT and Tlr4 KO neurons that responded to LPS
also responded to 100mM cinnamaldehyde (CA) and 100 nM
capsaicin (Fig. 1a,b,e), indicating that they are polymodal noci-
ceptor neurons13,14, and raising the possibility that the neuronal
response to LPS was mediated by the wide-spectrum chemo-
nociceptor channel TRPA1 (refs 13,15,16). Indeed, we found that
nodose neurons from Trpa1 KO mice responded to LPS with
signiﬁcantly lower incidence (6.6%, 14/212, Po0.001, Fisher’s
exact test; Fig. 1c,d) and amplitude than neurons obtained from
WT animals (Po0.01, unpaired t-test; Supplementary Fig. 1b).
Experiments using trigeminal (TG) sensory neurons yielded
similar results, namely, a large overlap of the neuron populations
sensitive to LPS and CA in the WT (89.3%, 50/56) and drastic
reduction in the incidence (5/250, Po0.0001, Fisher’s exact test;
Fig. 1d) and amplitude (Po10 4, unpaired t-test; Supplementary
Fig. 1) of responses to LPS in Trpa1 KO mouse neurons
compared with WT (56/394). Moreover, pre-application of the
TRPA1 inhibitor HC-030031 (ref. 17) nearly abolished TG
neuron responses to LPS (2/132, Po10 4, Fisher’s exact test;
Fig. 1d), while removal of the inhibitor unleashed LPS-induced
responses (17/132) mainly in CA-sensitive neurons (16/17;
Fig. 1d). Notably, responses to LPS in nodose neurons of Trpv1
KO mice18 were robust (Supplementary Fig. 1a) and nearly as
frequent (25/187, P¼ 0.25, Fisher’s exact test) as in WT mice
(Fig. 1d), indicating that TRPV1 channels are not a primary
target for LPS action in nociceptors. Responsiveness to LPS was
dose-dependent and could be detected for concentrations as low
as 100 ngml 1 and 1 mgml 1 for nodose (Fig. 1e) and TG
neurons (Fig. 1f), respectively. At the highest concentration of
LPS tested, the overlap between LPS and CA sensitivity was 67%
for nodose and 78% for TG neurons. Also, it is noteworthy that,
for concentrations up to 10 mgml 1 LPS, responsive neurons
belonged nearly exclusively to the TRPA1-positive population,
while at higher concentrations the response to LPS extended to
other populations.
LPS depolarizes TRPA1-expressing nociceptors. Simultaneous
monitoring of intracellular calcium levels and electrical activity in
cell-attached mode revealed that calcium elevations caused by
LPS in nodose neurons occurred during brief periods of action
potential ﬁring (Fig. 2a). Notably, excitatory effects of LPS on
electrical activity were similar in WT and Tlr4 KO mice (Fig. 2b).
During current-clamp recordings, a fraction (5/8) of cultured
nodose neurons expressing TRPA1 channels depolarized rapidly
(mean±s.e.m¼ 16±4mV), ﬁring trains of action potentials in
response to LPS (Fig. 2c). In contrast, these responses were not
observed (0/10) (P¼ 0.006, Fisher’s exact test) in neurons
insensitive to TRPA1 agonists (Fig. 2c,d).
To analyse whether LPS acts on the peripheral terminals of
primary sensory neurons expressing TRPA1, we recorded the
impulse activity of TG nerve afferents innervating the mouse
tongue ex vivo. Application of LPS onto the receptive ﬁeld of
sensory units, identiﬁed as nociceptive by their response to heat
or capsaicin, produced a signiﬁcant increase in the ﬁring
frequency in 50% of them, precisely those that were also activated
by the TRPA1 agonist allyl isothiocyanate (AITC; Supplementary
Fig. 2). This indicates that LPS activates the fraction of peripheral
nociceptor ﬁbres expressing TRPA1.
Taken together, these results demonstrate that the chemosen-
sitive cation channel TRPA1, but not the canonical LPS receptor
TLR4, is critical for the acute excitatory effects of LPS on
nociceptor sensory neurons.
LPS activates TRPA1 channels. Next, we determined whether
LPS stimulates TRPA1 channels by measuring [Ca2þ ]i changes
in Chinese hamster ovary (CHO) cells expressing recombinant
mouse TRPA1 channels (mTRPA1 cells)13. LPS induced a dose-
dependent and reversible increase of [Ca2þ ]i with an effective
concentration of 3.3±0.5 mgml 1 (mean±s.e.m for all values)
(Fig. 3a,b). LPS did not induce Ca2þ responses in Ca2þ -free
(plus 1mM EGTA) solutions (ratio change¼  0.0042±0.0008,
n¼ 46, P¼ 1.0; paired t-test), or in non-transfected CHO cells
(Fig. 3a), indicating that LPS induces Ca2þ inﬂux through
mTRPA1 channels in the plasma membrane. Importantly, LPS
also stimulated human embryonic kidney (HEK)-293 cells
transfected with human TRPA1 (Supplementary Fig. 3a), but
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was ineffective, at 3 mgml 1, on three other human TRP
channels known to be expressed in primary sensory neurons,
namely, the vanilloid receptor TRPV1, the menthol receptor
TRPM8 and the D9-tetrahydrocannabinol-activated receptor
TRPV2 (Supplementary Fig. 3b–d).
Stimulation of mouse TRPA1 by LPS was conﬁrmed in whole-
cell patch-clamp recordings in mTRPA1 cells; extracellular
application of LPS (20 mgml 1) induced a signiﬁcant increase
in the amplitude of non-selective cation currents (reversal
potential¼  2.7±1.9mV, n¼ 7; Fig. 3c,d). In contrast, LPS
was ineffective in non-transfected CHO cells (Fig. 3d,
Supplementary Fig. 4a,b). The maximal current increase induced
by the potent TRPA1 agonist AITC (20 mM) was approximately
eightfold larger than that elicited by 20 mgml 1 LPS (Fig. 3d),
indicating that LPS has lower efﬁcacy. Moreover, pre-application
of the TRPA1 inhibitor HC-030031 fully prevented the
activating effects of LPS (n¼ 5). The inhibition of
TRPA1 whole-cell current by HC-030031 was reversible on
wash and could be reinstated on reapplication of the blocker
(Supplementary Fig. 4c). At  75mV, current density
averaged  8.2±1.7 pA pF 1 in HC-030031 plus LPS and 
39.4±6.5 pA pF 1 after HC-030031 wash (n¼ 7, Po0.001,
paired t-test).
Next, we explored the mechanism(s) through which LPS
stimulates TRPA1. LPS could potentially activate TRPA1 by
modulating [Ca2þ ]i (refs 19,20). However, LPS was able to
stimulate TRPA1 in Ca2þ -free conditions (Fig. 3e, Fig. 4).
Alternatively, TRPA1 could be activated by an endogenous
electrophilic compound that could be eventually produced on
LPS application. However, LPS induced a signiﬁcant activation of
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Figure 1 | TRPA1 mediates stimulation of nociceptor neurons by LPS. (a–c) Representative examples of the effects of LPS (10 mgml 1) on [Ca2þ ]i levels
in nodose ganglion neurons isolated from WT (a), Tlr4 KO (b) and Trpa1 KO mice (c). Cinnamaldehyde (CA, 100mM) and capsaicin (Caps, 100 nM)
were applied to identify TRPA1- and TRPV1-expressing neurons, respectively. (d) Percentage of mouse nodose and TG sensory neurons responsive to LPS
(blue) or to LPS and CA (black). The labels ‘WTþHC’ and ‘WT after HC’ refer to the responses to LPS (10mgml 1) observed in the presence of
the TRPA1 inhibitor HC-030031 and after its removal, respectively. (e,f) Percentage of nodose (e) or TG (f) neurons responding to LPS (blue) or to LPS
and CA (black) as a function of LPS concentration.
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the AITC-insensitive TRPA1-mutant C622S in HEK-293 cells
(increase in Fura-2 ratio of 0.38±0.03, n¼ 36, Po0.01, paired
t-test). Analysis of the macroscopic TRPA1 currents activated by
LPS in Ca2þ -free conditions indicated a slowing of channel
deactivation, an acceleration of channel opening (Fig. 3e,
Supplementary Fig. 5) and a concomitant leftward shift in the
voltage dependence of channel activation (Fig. 3f). These data
demonstrate that, as occurs with other TRPA1 activators21,22, LPS
acts as a gating modiﬁer of TRPA1, destabilizing the closed
state(s) and stabilizing the open conformation(s).
LPS activates TRPA1 channels in a membrane-delimited
manner. To gain further insight into the mechanism of TRPA1
activation by LPS, we performed patch-clamp recordings in cell-
free outside-out patches in the absence of intracellular and
extracellular Ca2þ . Under these conditions, extracellular appli-
cation of LPS enhanced TRPA1 currents (6.1±1.6-fold increase
at  75mV; P¼ 0.018, n¼ 5, paired t-test; Fig. 4a,b). The single-
channel conductance, estimated from linear ﬁts to currents
evoked during voltage ramps, was nearly identical in control and
in the presence of LPS (96±3 pS and 94±2 pS, respectively;
n¼ 5, Fig. 4b), and the TRPA1 antagonist HC-030031 induced a
powerful inhibition of LPS-induced single-channel currents
(97±2%, n¼ 5, Fig. 4a,b). In outside-out patches held at
þ 75mV, with Ca2þ -free extracellular and intracellular solu-
tions, the basal open probability was on average 0.014±0.004
(Fig. 4c), while mean closed time and mean open time were
2.0±1.2 s and 8.1±1.0ms, respectively, (n¼ 5). In these
patches, LPS induced a 5.7±1.6-fold increase in the open prob-
ability (P¼ 0.023), a 4±1-fold reduction of the mean closed time
(P¼ 0.0016) and a 1.8±0.4-fold increase in the mean open time
(P¼ 0.04; n¼ 5, paired t-test; Fig. 4d). Of note, we recorded
half-sized openings, which may reﬂect the incidence of sub-
conductance open state(s).
LPS and endogenous TRPA1 agonists have synergistic effects.
One fundamental aspect of TRPA1 function is to act as molecular
integrator for multiple irritants and inﬂammatory mediators15,23.
Thus, it was important to determine whether the effects of LPS on
TRPA1 could be potentiated by other algesic compounds. At sites
of infection and inﬂammation, various endogenous molecules are
generated that could sensitize the response of TRPA1 to LPS. In
particular, inﬂammation increases the local levels of 4-hydroxy-2-
nonenal (HNE) and other lipid peroxidation products that are
potent stimulators of TRPA1 (refs 24,25). Thus, we hypothesized
that LPS and HNE may act synergistically on TRPA1. Indeed, the
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Figure 2 | E. coli LPS excites TRPA1-expressing sensory neurons. (a) Simultaneous recording of [Ca2þ ]i level (green trace) and instantaneous ﬁring
frequency (black dots) in cell-attached mode in a nodose neuron from a Tlr4 KO mouse. The large calcium transients (upper graph) during LPS
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(c) Examples of recordings of membrane potential in the perforated-patch current-clamp mode (Ihold¼0pA) in two nodose neurons. LPS (10 mgml 1)
induces rapid depolarization and ﬁring of action potentials in the TRPA1-expressing neuron (that is, AITC positive; upper traces). In contrast, LPS had no
effect on membrane potential in the TRPA1-negative neuron (lower traces). (d) Average±s.e.m. depolarization of the resting membrane potential
produced by LPS (n¼ 5) and AITC (AITC) or CA (n¼ 10) in TRPA1-expressing neurons (solid bars). The dashed bars represent the average depolarization
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co-application of low concentrations of HNE and LPS produced a
strong potentiation of TRPA1 activity, resulting in much larger
currents than the sum of each agonist applied alone
(Supplementary Fig. 6). As expected for a TRPA1-dependent
effect, these currents were fully suppressed by HC-030031
(Supplementary Fig. 6).
The shape of lipid A determines TRPA1 activation by LPS.
Suspecting that LPS insertion in the plasma membrane is
responsible for its stimulatory action on TRPA1 channels, we
tested the effect of lipid A, the membrane-anchored lipid moiety
of LPS26. Application of 50 mgml 1 diphosphoryl lipid A from E.
coli induced [Ca2þ ]i responses in mTRPA1 cells, but not in
control cells (Fig. 5a). Moreover, application of lipid A to nodose
neurons produced robust Ca2þ elevations exclusively in a
subpopulation (9/41, 22%) of CA-activated neurons (Fig. 5b).
Interestingly, synthetic monophosphoryl lipid A also activated
mTRPA1 cells (Supplementary Fig. 7) ruling out a biological
contaminant during LPS puriﬁcation as a possible source of the
effect.
The intrinsic conformation of lipid A is critical for LPS
bioactivity (for example, induction of cytokine production), with
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conical shapes conferring more activity than cylindrical ones27,28.
This conformation is largely determined by the number of
charged phosphate groups and acyl chains, and varies among
different bacterial strains26. We found that LPSs with
asymmetrical hexa-acyl lipid A (E. coli, Salmonella
typhimurium and Klebsiella pneumoniae) induced the strongest
TRPA1 responses (Fig. 5c,d). In comparison, LPSs with
asymmetrical penta-acyl lipid A (Serratia marcescens,
Pseudomonas aeruginosa) induced smaller effects on TRPA1.
Finally, LPS from Neisseria meningitidis, with symmetrical
hexa-acyl lipid A, and from S. minnesota, which is known to
form symmetrical lamellar structures, had virtually no effect on
TRPA1. Very similar results were obtained in cultured TG
neurons: the percentage of neurons responding to LPS followed
the sequence (E. coli4S. marcescens4S. minnesota) and the great
majority of LPS responders had a nociceptive phenotype
(Fig. 5e,f). These results strongly suggest that the capacity of a
given LPS to activate TRPA1 correlates with its ability to induce
mechanical alterations in the plasma membrane. We also found
that trinitrophenol (TNP), a negatively charged amphiphatic
compound inducing mechanical tension of the lipid membrane,
and known to modulate the gating of mechanosensitive
channels29, including TRPA1 (ref. 30) also potentiated LPS
activity. Pretreatment with TNP strongly potentiated [Ca2þ ]i
responses to low concentrations of LPS in mTRPA1 cells
(Supplementary Fig. 8a–d).
LPS effects on TRPA1 are TLR4 independent. Generally, LPS
effects on neurons have been linked to activation of the TLR4
signalling pathway10. However, as shown earlier, we found that
the excitatory effects of LPS were still observed on sensory
neurons isolated from Tlr4 KO mice. We also tested CLI-095, a
novel speciﬁc inhibitor of TLR4 signalling31. As shown in
Fig. 6a–c, pretreatment for 10min with 1 mM CLI-095 did not
affect the subsequent response to LPS in nodose neurons; neither
the percentage of responding neurons nor the amplitude of the
response was signiﬁcantly affected. Similar results were obtained
in TRPA1-expressing CHO cells (Supplementary Fig. 9). In
addition, CHO cells transfected with human TLR4 did not show a
TRPA1-like current when acutely exposed to LPS (Supplementary
Fig. 10). Altogether, these results strongly support a TLR4-
independent mechanism of action of LPS on TRPA1 channels.
We took additional steps to verify that activation of TRPA1
was truly mediated by LPS. To minimize the possible role of a
contaminant, we tested ultrapure forms of LPS (see Methods). As
shown in Supplementary Fig. 11, ultrapure LPS from E. coli
(2 mgml 1) also activated TRPA1-expressing cells. Moreover, the
–20
0
20
40
ba
**
*
5 s
*
104 103 102 101 100
–5
0
10
Events
104 103 102 101 100
–5
5
10
Events
50 ms
60 s
c
HC-030031
Cu
rre
nt
 (p
A)
+75 mV
–75 mV
LPS
*
*
*
Control
LPS
d
20 pA
50 mV
LPS + HC-030031
5
0
Figure 4 | LPS activates TRPA1 channels in a membrane-delimited manner. (a) Time course of current amplitudes recorded in outside-out patches
of TRPA1-expressing CHO cells at –75 and þ 75mV. Currents were elicited by voltage ramps from  100 to þ 100mV from a holding potential
of 0mV. The arrow indicates the moment of application of LPS (10 mgml 1) and the horizontal bar indicates the period of exposure to 50mM HC-030031.
The coloured asterisks mark the time points at which the corresponding current traces shown in b were recorded. Single-channel records in the outside-out
conﬁguration at þ 75mV, in control solution (c) and in the presence of 10mgml 1 LPS (d). Events marked with an asterisk are displayed at an
expanded timescale. The histograms on the left show the corresponding distributions of the current amplitudes. All records in the ﬁgure were obtained
in Ca2þ -free conditions.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4125
6 NATURE COMMUNICATIONS | 5:3125 | DOI: 10.1038/ncomms4125 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
ultrapure form of S. minnesota R595, at a 10 times higher
concentration, showed almost no response, similar to the results
obtained from a different source (see Fig. 5c,d). Strikingly, an
ultrapure LPS from Rhodobacter sphaeroides, which acts as a
competitive antagonist of TLR4 (ref. 32), also activated TRPA1-
expressing cells (Supplementary Fig. 11), strongly suggesting a
TLR4-independent mechanisms of action. In contrast, the same
preparations of LPS had the expected effects on human TLR4
signalling (Supplementary Fig. 11d).
Polymyxin B is a cationic cyclic polypeptide antibiotic that is
widely used to neutralize the effects of endotoxin contamination
in biological samples33. The action of polymyxin B is based on its
binding, by electrostatic interaction, to the anionic lipid A.
Incubation of LPS with polymyxin B completely eliminated the
activation of TRPA1 by LPS (Fig. 6d,e). In contrast, activation of
TRPA1 by AITC was minimally reduced (Fig. 6f). This result
suggests that the inhibitory action of polymyxin B is not directly
on the channel (for example, pore block) and further implicates
lipid A in the effects observed.
Acute neuropeptide release by LPS depends on TRPA1 activity.
TRPA1 participates in neurogenic inﬂammation and vasodila-
tion34–36. To test whether activation of peptidergic sensory
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terminals by LPS leads to neuropeptide release and neurogenic
inﬂammation14,37, we used an isolated mouse trachea
preparation. The trachea is densely innervated with peptidergic
vagal ﬁbres that release calcitonin gene-related peptide (CGRP) in
response to capsaicin38,39. Brief incubation of tracheal halves with
acrolein, an electrophilic TRPA1 activator and product of
oxidative stress, also present in fumes and as a toxic metabolite
of chemotherapy agents15, produced a dose-dependent release
of CGRP (Supplementary Fig. 12). Application of LPS
(30–100 mgml 1) to tracheal halves induced a modest but signi-
ﬁcant CGRP release (Fig. 7a). In addition, a brief pretreatment of
the trachea with the membrane crenator TNP produced a massive
potentiation of the CGRP release evoked by LPS (Po10 4) and
by acrolein (Po0.01; Fig. 7a). Notably, responses to individual
agonists, or potentiated response to LPS in the presence of TNP
were fully abrogated in Trpa1 KO mouse tracheas (Fig. 7a),
indicating that they depend strictly on activation of TRPA1
channels. We also observed a fourfold potentiation of CGRP
release from the trachea by LPS in the presence of the endogenous
TRPA1 agonist HNE (Fig. 7b), fully consistent with the
synergistic action of both agonists on TRPA1 whole-cell
currents as we have shown (Supplementary Fig. 6). Collectively,
these results indicate that LPS, both alone and in combination
with other endogenous inﬂammatory mediators, can activate
TRPA1 in sensory nerve terminals leading to acute neurogenic
inﬂammation.
Neurovascular responses to LPS involve activation of TRPA1.
Systemic bacterial invasion can cause massive peripheral
vasodilation, leading to a severe drop in blood pressure, a life-
threatening condition known as septic shock40. Considering that
chemical stimulation of TRPA1 in sensory ﬁbres innervating
resistance arteries induces potent vasodilation24,34–36, we tested
whether this channel was involved in the vascular response
to LPS. Using pressure myography ex vivo, we found that
LPS (100 mgml 1) induced a strong dilation in WT mouse
mesenteric arteries precontracted with the alpha1 adrenergic
agonist phenylephrine (2 mM; Fig. 7c and Supplementary
Fig. 13a). Notably, this effect was signiﬁcantly reduced by the
speciﬁc TRPA1 inhibitor HC-030031 (10 mM) and by genetic
ablation of TRPA1 (Fig. 7c and Supplementary Fig. 13b).
Moreover, in Trpa1 KO animals, the residual LPS-induced
dilation was completely insensitive to HC-030031 (Fig. 7c and
Supplementary Fig. 13b). Thus, TRPA1 appears to participate in
the vasodilation response to LPS, although other yet unidentiﬁed
targets also appear to contribute to the arterial vasomotor
responses.
Acute LPS-induced hypersensitivity engages TRPA1 but
not TLR4. The typical symptoms of local Gram-negative bacterial
infections include inﬂammation, pain and mechanical hyper-
sensitivity41,42. They were readily reproduced experimentally
with intraplantar injections of puriﬁed E. coli LPS in WT mice
(Fig. 7d,e). Consistent with a major role of TRPA1 as a LPS
effector, we found that such responses were severely attenuated
in Trpa1 KO mice (Fig. 7d,e). A similar attenuation of mechanical
hyperalgesia to LPS injection in Trpa1 KO mice was reported
recently43. Moreover, the local inﬂammation caused by LPS
molecules with different lipid A shape was strongly correlated
with their ability to stimulate mTRPA1 in vitro (r¼ 0.91, Po0.01;
Fig. 7f) linear correlation coefﬁcient (n¼ 7). In contrast, acute
pain responses, local tissue swelling and mechanical hyperalgesia
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developed normally in Tlr4 KO mice following LPS injection
(Supplementary Fig. 14). Notably, mechanical hyperalgesia
resolved more rapidly in Tlr4 KO mice compared with wild
type, suggesting that immune response pathways are engaged by
LPS in a slower timescale compared with TRPA1 activation.
TRPA1 is not critical for LPS systemic inﬂammatory response.
As deletion of TRPA1 produces such prominent effects on
nociceptive and neurovascular response to LPS, we wondered
whether other, well-established, systemic responses to LPS were
affected as well. In mice, i.p. application of high doses of LPS
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produces a profound and long-lasting hypothermia44. As
previously described, the injection of 3mg kg 1 E. coli LPS
produced a marked hypothermia in WT mice (Supplementary
Fig. 15). The severity and time course of this hypothermic
response was nearly identical in Trpa1 KO littermates.
Activation of TLR4 by LPS is known to potently activate
immune cells (for example, hepatic macrophages) to produce and
release proinﬂammatory cytokines such as TNF-a and IL-6
(refs 4,45). Indeed, i.p. LPS treatment (0.75 and 1mg kg 1
for 1 h) increased dose dependently circulating serum IL-6
levels from an undetectable baseline after saline injection
(Supplementary Fig. 16a). As was the case for thermoregulatory
responses, we did not ﬁnd differences in the levels of IL-6
between both genotypes of mice. Moreover, LPS treatment
(1mg kg 1 for 1 h) also increased IL-6 messenger RNA levels in
the liver in both types of mice similarly (Supplementary Fig. 16b).
Discussion
Here we demonstrate that TRPA1 channels are key participants
in the biological response to LPS, a microbial signature molecule,
translating the presence of elevated LPS into a rapid nociceptor
response and neurogenic inﬂammation. Therefore, LPS appears
as a totally novel class of biological toxin among the large number
of natural compounds that are detected by TRPA1 channels
(reviewed by Nilius et al.16). The ancient nature of LPS and the
fact that the role of TRPA1 in chemical avoidance is conserved
from ﬂies to mammals underscores the evolutionary signiﬁcance
of this alert mechanism in animals14,46–48. It is noteworthy that
bacterial sepsis is accompanied by severe redox imbalance,
favouring the oxidant state49, a condition that also leads to
robust TRPA1 channel activation24,50.
Our ﬁndings also raise the question of how this channel can
function as such an extremely broadly tuned chemo-nocisensor. In
the light of previous studies and of the present results, it seems
clear that rather than using speciﬁc molecular determinants (that
is, the key and lock concept), TRPA1 activation relies on the
general physico-chemical properties of the agonist. Whereas highly
reactive electrophilic irritants are detected by their capacity to
modify covalently key amino-acid residues in the amino terminus
of the TRPA1 channel47,51, our results suggest that LPS modulates
TRPA1 activity by inducing mechanical perturbations in the
plasma membrane. This result is in line with the known
mechanosensing function of TRPA1 in visceral52 and
somatic53,54 neurons. The activation of TRPA1 by LPS in cell-
free membrane patches indicates that the mechanism underlying
this effect does not require other intermediate molecules, but
additional experiments, including the characterization of LPS
action after incorporation of TRPA1 into artiﬁcial lipid bilayers of
deﬁned composition, are needed to substantiate this point.
Nevertheless, it is noteworthy that different forms of LPS
activated TRPA1 in proportion to their ability to produce
inﬂammation in vivo, which suggests a close relation between
both processes. Recently, Hardie and Franze55 showed, in a very
elegant way, that activation of light-sensitive TRP and TRPL
channels in Drosophila photoreceptors is mediated by rapid
mechanical perturbation of the plasma membrane caused by
phosphatidylinositol 4,5-bisphosphate (PIP2) depletion
downstream of PLC activation by light. This study is very
relevant to the hypothetical activation of TRPA1 under
pathophysiological conditions because TRPA1 is also activated
by G-protein-coupled receptors that activate PLC and deplete PIP2
(refs 15,23). In the context of infection, the production of some
inﬂammatory mediators (for example, bradykinin and trypsin)
that couple to Gq/11 will also lead to PIP2 depletion. Thus, the
mechanical perturbations produced by LPS hypothesized in our
study could act synergistically with those produced by changes in
PIP2 levels, leading to TRPA1 gating.
Sensory neurons express a number of TLR4 signalling
elements, including TLR4, making it plausible that TLR4
signalling participates in sensory responses to LPS11. Indeed,
several recent studies have implicated TLR4 in rapid responses to
LPS in sensory neurons, including the sensitization of TRPV1
channels10. However, a number of results clearly indicate that
TLR4 is dispensable for the excitatory actions of LPS on TRPA1.
First and foremost, responses in sensory neurons from Tlr4 KO
mice were indistinguishable from those observed in WT animals.
Second, incubation with a speciﬁc inhibitor of TLR4 signalling
did not affect responses to LPS in TRPA1-expressing neurons or
recombinant TRPA1 channels. Moreover, acute pain and tissue
swelling peaked normally in Tlr4 KO mice in vivo. Obviously,
under in vivo conditions, circulating LPS will engage the available
TLR4 machinery, including the production of proinﬂammatory
cytokines, which could participate in the slow sensitization of
nociceptors. Consistent with this view, we observed a faster
resolution of the mechanical hypersensitivity, following local LPS
injection, in Tlr4 KO mice. In vivo, we envision both effector
pathways of LPS acting synergistically on somatic and visceral
neurons.
Our observation that LPS excites somatic and visceral
nociceptor neurons via a mechanism dependent on TRPA1
activation and independent of TLR4 can readily explain acute
pain and neurogenic inﬂammation induced by LPS. Similar
concentrations of LPS have been used to evoke pain behaviour in
experimental animals42. The activation of TLR4 occurs at lower
LPS levels than those required to activate TRPA1 channels.
However, severe endotoxemia can bring plasma LPS levels into
the micromolar range56, levels also encountered in urine and
locally inﬂamed tissues57. Moreover, we found strong (that is,
10-fold) potentiation of LPS-induced activation of TRPA1 by
other TRPA1 agonists, including endogenous modulators (for
example, HNE), suggesting that in the context of a bacterial
infection in vivo, the levels of LPS required to activate TRPA1
may be lower than what we found experimentally. It should be
noted that the ex vivo preparations we used (that is, the superfused
trachea and the isolated tongue), in contrast to the skin in vivo,
cannot reﬂect secondary inﬂammatory reactions, like plasma extra-
vasation, accumulation of inﬂammatory mediators (for example,
bradykinin, thrombocytes and immune cells), which, together,
may complement or amplify, like we found with HNE or acrolein,
the excitatory effects of LPS on TRPA1 to activate nociceptors58.
The modest but signiﬁcant effect of LPS alone on tracheal CGRP
release is not surprising, because even prostaglandin E2, the most
widely acknowledged nociceptor sensitizer, shows no effect of its
own on nociceptor discharge and CGRP release but ‘only’
facilitates heat and chemical responses59. Finally, these avascular
ex vivo preparations cannot be compared directly with dissociated
sensory neurons in culture with respect to chemosensitivity,
because the nerve endings do not reach the very surface of the
mucosa, formed by epithelial cells and their tight junctions.
TRPA1-mediated calcium inﬂux in sensory terminals leads
to release of neuropeptides13,24, thereby triggering rapid
TRPA1-dependent vasodilation, local inﬂammation and
sustained mechanical hyperalgesia. Recently, it was established
that TRPA1-mediated substance P release in the colon plays a
necessary role in experimental colitis60, providing further support
for a causal link between TRPA1 channels and neuroimmune
processes. Other studies have indicated the essential role of
TRPA1 in the pathophysiology of asthma37, a disease with a
signiﬁcant immunological component.
We found that in the absence of TRPA1 the proinﬂammatory
and pro-algesic actions of LPS are severely curtailed. Interaction
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of LPS with the MD-2–TLR4 complex leading to activation of the
transcription factor nuclear factor-kappaB (NF-kB) and cytokine
production is the canonical pathway of LPS signalling2. The
identiﬁcation of TRPA1 as a functional target for LPS may
represent an important missing link between the stimulation of
afferent sensory ﬁbres and the immune responses during a
bacterial challenge. We tentatively conclude that TRPA1 channels
and pattern receptors like TLR4 act as synergic sensory
mechanisms, alerting the host about the presence of pathogens,
allergens and environmental irritants3. TRPA1 would be involved
in the early steps of the response cascade, sensing potentially
damaging compounds, in parallel with the well-established
production of proinﬂammatory cytokines. The recent discovery
of activation of the NF-kB signalling pathway following TRPA1
activation provides independent support to our view61. Thus,
identiﬁcation of TRPA1 as a new target for LPS opens novel
avenues for the treatment of adverse biological responses of Gram-
negative bacterial infections. Finally, the recent report describing
the activation of nociceptors by N-formylated peptides and the
pore-forming toxin a haemolysin isolated from bacteria, by
mechanisms independent of immune pathways62, suggests that
direct activation of nociceptors by bacterial products may be a
more general signalling mechanism than previously recognized.
Methods
Animals. Experiments were performed in accordance with the guidelines
established by the European Communities Council Directive (86/609/ECC), by
Spanish Royal Decree 1201/2005 and the Ethics Committee of the Catholic
University, Leuven.: Tlr4 KO mice on a C57BL/6 background, originally generated
by Hoshino et al.63 were kindly provided by C Guerri Centro de Investigacio´n
Prı´ncipe Felipe (CIPF) and by H Hammad and B Lambrecht (VIB, Ghent,
Belgium). Trpa1 KO mice were provided by D Corey64. Trpv1 KO mice, originally
generated in D Julius laboratory18, were obtained from Jackson.
Neuronal culture. Neuronal culturing methods were similar to those used pre-
viously65,66. TG and nodose ganglia were isolated from young adult male mice
(postnatal months 1–3), WT and Trpa1 KO siblings64, Tlr4 KO (ref. 63) and Trpv1
KO (ref. 18), and incubated for 1 h with 0.07% collagenase XIþ 0.3% Dispase at
37 C. Thereafter, ganglia were mechanically dissociated and cultured in minimal
essential medium with Earle’s balanced salt solution and L-Glutamine (Invitrogen)
supplemented with 10% fetal bovine serum (Invitrogen), 1% minimal essential
medium vitamin solution (Invitrogen), 100 mgml 1 penicillin/streptomycin and
100 ngml 1 nerve growth factor (NGF). Cells were plated on poly-L-lysine-coated
glass coverslips and used after 1 day in culture.
Cell culture. CHO-K1 cells, from the American Type Culture Collection,
were cultured in DMEM containing 10% of fetal bovine serum, 2% glutamax
(Invitrogen), 1% non-essential amino acids (Invitrogen) and 200 mgml 1
penicillin/streptomycin. An inducible CHO-K1 cell line stably expressing mouse
TRPA1 channels was kindly provided by Ardem Patapoutian (The Scripps
Research Institute, USA)13 and cultured as detailed for the parental cell line.
Expression of TRPA1 was induced by application of 0.25–0.5 mgml 1 tetracycline
4–18 h before recording. HEK-293 cells, from the European Collection of Cell
Cultures (Salisbury, UK), were seeded in 18mm glass coverslips coated with
poly-L-lysine (0.1mgml 1) and grown in DMEM containing 10% (v/v) human
serum, 2mM L-glutamine, 2Uml 1 penicillin and 2mgml 1 streptomycin at
37 C in a humidity-controlled incubator with 10% CO2. Human TRPA1, TRPV1,
TRPM8 and TRPV2 were cloned in the pAGGS-IRES-GFP vector and transiently
transfected in HEK-293 cells using Trans-IT-293 reagents (Mirus, Madison, MI,
USA). Transfected cells were identiﬁed by the expression of GFP (green ﬂuorescent
protein).
Calcium imaging. Calcium-imaging experiments were conducted with the ﬂuor-
escent indicator Fura-2. Cells were incubated with 5 mM Fura-2-acetoxymethylester
(Invitrogen) for 60min at 37 C. Fluorescence measurements were made with a
Zeiss Axioskop FS (Germany) upright microscope ﬁtted with an ORCA ER charge-
coupled device camera (Hamamatsu, Japan). Fura-2 was excited at 340 and 380 nm
with a rapid switching monochromator (TILL Photonics, Germany). Mean ﬂuor-
escence intensity ratios (F340/F380) were displayed online with Metaﬂuor software
(Molecular Devices, Sunnyvale, USA). The control bath solution contained
(in mM) 140 NaCl, 3 KCl, 2.4 CaCl2, 1.3 MgCl2, 10 HEPES and 10 glucose, and was
adjusted to a pH of 7.4 with NaOH. Bath temperature was maintained at 34–36 C
by a custom-built Peltier device.
Patch-clamp electrophysiology. Whole-cell voltage-clamp recordings were per-
formed with standard patch pipettes (3–6MO resistance) made of borosilicate glass
capillaries (Harvard Apparatus Ltd, UK) and contained (in mM) 140 NaCl, 5 CsCl,
10 EGTA, 10 HEPES, (305mOsm kg 1; pH 7.4, adjusted with NaOH). The control
bath solution was kept at room temperature except for HC-030031 experiments
(32±1 C). During calcium-free experiments, the bath solution was as follows
(in mM): 140 NaCl, 3 KCl, 1.3 MgCl2, 10 HEPES, 1 EGTA, 10 glucose. Current
signals were recorded with an Axopatch 200B patch-clamp ampliﬁer (Molecular
Devices). Stimulus delivery and data acquisition were performed using pClamp 9
software (Molecular Devices). Current development was monitored with repetitive
(0.5Hz) injections of 500ms duration voltage ramps from  100 to þ 100mV,
and the voltage steps consisted in a series of 400ms duration steps ranging from
 150 to þ 175mV followed by an invariant pulse to  75mV (400ms). The
holding potential was set to 0mV.
Outside-out patch recordings on mTRPA1 cells were performed in the absence
of intracellular and extracellular Ca2þ . Patch pipettes (3–6MO resistance)
contained the standard internal solution (see above) and the calcium-free bath
solution (see above). Currents were sampled at 20 kHz and low-pass ﬁltered at
2 kHz. Current development was continuously monitored with repetitive (0.5Hz)
injections of 500ms duration voltage ramps from  100 to þ 100mV from a
holding potential of 0mV.
Patch-clamp data were analysed with WinASCD software written by Dr Guy
Droogmans (ftp://ftp.cc.kuleuven.ac.be/pub/droogmans/winascd.zip) and Origin
7.0 (OriginLab Corporation).
Current-clamp recordings of cultured nodose neurons. Perforated-patch cur-
rent-clamp recordings were performed on cultured nodose neurons from adult
mice. Standard patch pipettes (2–5MO) were made of borosilicate glass capillaries
(Harvard Apparatus Ltd) and contained (in mM) 105 K gluconate, 35 KCl, 10
NaCl, 10 HEPES, 0.1 EGTA and 1mgml 1 amphotericin B, pH 7.4. The external
solution was identical to the one used in voltage-clamp recordings. Before electrical
recordings, neurons expressing TRPA1 were identiﬁed with Ca2þ micro-
ﬂuorimetry (see above) by their response to 10 mM nifedipine, a potent, reversible
and non-electrophilic activator of TRPA1 channels22.
Recordings of lingual nerve afferents. The animals were killed by exposure to
CO2 and quickly decapitated. The tongue was carefully dissected, split at the
midline and placed in a recording chamber and continuously perfused
(3mlmin 1) with physiological saline (in mM): NaCl 128, KCl 5, NaH2PO4 1,
NaHCO3 26, CaCl2 2.4, MgCl2 1.3 and glucose 10. This solution was gassed with
carbogen to pH 7.4. Temperature of the solution was kept around 34 C and could
be modiﬁed with a water-cooled, home-designed, Peltier device. Fine ﬁlaments of
the lingual nerve were split with ﬁne forceps and placed on a platinum electrode for
extracellular recording. Electrical signals were alternating current-ampliﬁed and
high pass ﬁltered. Data were captured and analysed using a CED 1401 interface and
Spike 2 software (Cambridge Electronic Design, Cambridge, UK). Single units were
detected online using a threshold-based criterion and sorted manually afterwards
to remove artefacts.
Arterial pressure myography. Mice were killed by CO2 inhalation and decap-
itation. The mesenteric bed was removed and transferred to ice-cold solution
(in mM): NaCl 124, NaHCO3 25, KCl 5.5, KH2PO4 1.2, MgSO4 1.2, glucose 5.5,
CaCl2 2.5 (pH 7.4 when aerated with 95% O2–5% CO2). Second- and third-branch
arteries were removed, dissected free of the adherent fat, cannulated and mounted
in a pressure myograph (Danish Myotechnology, Aarhus, Denmark) for
measurement of diameter. Before testing the effect of LPS or HC-030031 on arterial
tone, arteries were allowed to equilibrate at 70mmHg and 37 C, and after 60min
were precontracted with phenylephrine 2 mM.
Assay of TLR4 activity. Activation of TLR4 by different forms of ultrapure LPS
was tested in HEK-Blue-hTLR4 cells (InvivoGen, San Diego, USA). These HEK-
293 cells stably express human TLR4, MD-2, CD14 and an NF-kB-inducible
alkaline phosphatase reporter gene system. Expression of secreted alkaline phos-
phatase was detected with Quanti-Blue (InvivoGen) and quantiﬁed by reading the
absorbance with a spectrophotometer at 620–655 nm. Cells were maintained in
complete DMEM with selective antibiotics, as described by the manufacturer’s
instructions (InvivoGen). For testing, cells were plated on 96-well plates at 25,000
cells per well, and were incubated with different concentrations of LPS for 16 h.
Analysis of IL-6 levels. WT and TRPA1 KO mice were injected i.p. with 0.75 or
1mg kg 1 E. coli LPS 055:B5 (Sigma-Aldrich) or saline and killed by decapitation
1 h later. Serum and liver were quickly collected and immediately frozen and stored
at  80 C. IL-6 serum levels were determined by enzyme-linked immunosorbent
assay (R&D Systems, Minneapolis, USA).
Liver analysis of IL-6 messenger RNA levels was performed by
reverse transcriptase PCR. Total RNA was extracted using Trizol Reagent
(Invitrogen). Reverse transcriptase PCR was performed with a speciﬁc
set of primers: forward: 50-GCCACTCCTTCTGTGACTCCAGCT-30 .
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Reverse: 50-ACCACTTCACAAGTCGGAGGCTT-30 . Hypoxanthine guanine
phosphoribosyl-transferase was used as a housekeeping gene. The ampliﬁed
products were resolved in a 2% agarose gel and quantiﬁed by densitometry using a
digital imaging system (Molecular Analyst, Bio-Rad). The PCR products were
digested with speciﬁc restriction enzymes to determine their speciﬁcity.
CGRP enzyme immunoassay and analysis. The CGRP content of the incubation
ﬂuid was measured using a commercial enzyme immunoassay kits with a detection
threshold of 2 pgml 1 (Bertin Pharma, Montigny-le-Bretonneux, France). For this
purpose, 100ml ﬂuid samples were stored on ice and mixed, immediately following
the trachea incubation period, with 25 ml of ﬁvefold concentrated commercial
CGRP enzyme immunoassay buffer that contained a cocktail of peptidase inhibi-
tors. The CGRP contents were determined after the end of the experiment; the
antibody reactions took place overnight. Enzyme immunoassay plates were scored
photometrically using a microplate reader (Dynatech, UK). All results are pre-
sented as measured by the enzyme immunoassay in pg CGRP per ml incubation
ﬂuid. To reduce interindividual and day-to-day baseline variability, the data were
normalized to the second baseline value (before any stimulation). This value was
subtracted from all data points so that only the absolute change in CGRP release
(D pgml 1) is displayed in the ﬁgures.
Statistical comparisons were performed using the Statistica 7 software (Statsoft,
Tulsa, USA). The baseline-normalized DCGRP values were entered into a one-way
analysis of variance followed by Fisher’s least signiﬁcant difference test, focusing on
the peak values of stimulated CGRP release; *Po0.05 was considered signiﬁcant.
Data points represent means±s.e.m. of the given number (n) of experiments.
Behavioural testing. Behavioural studies were performed on littermates that were
wild type or homozygous null at the Trpa1 or Tlr4 allele. All experiments were
scored by a tester blind to genotype and to drugs injected. A total of 51 wild type,
25 Trpa1 KO and 6 Tlr4 KO male mice (2–3 months old) were used.
To measure acute nocifensive responses, mice were placed within transparent
plastic cylinders and allowed to accommodate for 2 h. LPS (5 mgml 1) was
prepared in PBS and delivered via intraplantar injection in a volume of 10 ml using
a 30G needle coupled to a Hamilton syringe. Immediately after injection,
nocifensive time was scored as the total time spent licking, lifting, guarding,
shaking or biting of the injected hind paw over a period of 10min. A separate
group of animals received injection of vehicle alone.
Mechanical thresholds were determined with Von Frey hairs using a modiﬁed
version of Dixon’s up-down method67. Procedures and intraplantar dosis of LPS
were identical to those used for nocifensive responses. Mice were placed in
transparent plastic cylinders (13 cm diameter 8 cm height) on a metal mesh
platform and calibrated von Frey ﬁlaments were applied to the plantar surface of
the hind paw for up to 2 s with sufﬁcient force to cause the ﬁlament to bow. Brisk
withdrawal of the hind paw during or immediately after application was considered
a positive response. The threshold force required to elicit withdrawal of the paw
(50% hind paw withdrawal) was determined from two separate trials. Data
presented are from both left and right hind paws averaged together, as there were
no laterality effects.
To examine the effects of LPS on body temperature (Tb), animals (adult male
mice) were adapted to a Plexiglass chamber (15 15 30 cm3) in a room at
23±1 C. Baseline rectal temperature was recorded with a thermoprobe connected
to a digital thermometer (Lendhermack, model IM902C). At time zero (10:00 day
time), immediately after a second measure of Tb, vehicle (PBS) or 3mg kg 1 of
E. coli LPS were injected i.p. Thereafter, Tb was monitored at 1 h interval for 7 h,
and the following morning.
Chemical reagents. LPS from E. coli, S. typhimurium, S. minnesota and
P. aeruginosa (puriﬁed by gel-ﬁltration chromatography), and K. pneumoniae,
S. marcescens (puriﬁed by phenol extraction) were purchased from Sigma-Aldrich.
N. meningitidis LPS was puriﬁed by phenol extraction at the Center for Vaccines
Research and Production (Finlay Institute, Havana, Cuba). The quality of this LPS
(40.5 106 EUml 1) was determined with a Kinetic-QCL Limulus amebocyte
lysate, using the programme Wiea QCL and a Lonza kit. LPSs were dissolved as a
stock solution in endotoxin-free distilled water, or PBS for behavioural experi-
ments, at a concentration of 5mgml 1. Other ultrapure forms of LPS were
purchased from InvivoGen (San Diego, USA), obtained by repeated phenol
extractions and prepared as sterile stock solutions with sterile water and diluted
right before use. These included LPS from E. coli strain 0111:B4, S. minnesota and
R. sphaeroides. Table 1 summarizes the source and characteristics of the different
LPS used.
Diphosphoryl lipid A (from E. coli F583 Rd mutant, Sigma) was dissolved in a
glass tube at a concentration of 1mgml 1 in chloroform/methanol (3:1 v/v). The
suspension was heated up to 40 C and solvent was dried by rotary evaporation
under a stream of N2. The glass tubes were supplemented with extracellular
solution and subjected to sonication for 40min. Synthetic monophosphoryl lipid A
(InvivoGen) was prepared as a 1-mgml 1 solution in dimethyl sulphoxide
(DMSO). Control experiments contained the same concentration of vehicle.
CLI-095 (InvivoGen), also known as TAK-242, was prepared as a 3-mM stock
solution in DMSO. Polymyxin B (InvivoGen) was prepared as a 50-mgml 1 stock
in distilled water. AITC, CA, TNP and HNE were stored as stock solutions and
diluted immediately before the experiments. HC-030031 was purchased from
Tocris and stored in a DMSO solution at 100mM.
Data analysis. Data are reported as mean±s.e.m. Dose–response data were
normalized to the maximum response of the drug in each case and then were ﬁtted
with the Hill equation using the Levenberg–Marquardt method implemented in
Origin 7.0 software. The s.e.m. were used as weights in ﬁtting where applicable.
When comparing two means, statistical signiﬁcance (Po0.05) was assessed by
Student’s two-tailed t-test. When comparing proportions between two experi-
mental groups (for example, percentage of responding neurons), we used Fisher’s
exact test.
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